AIMD Ainos: Enterprise Value-to-Revenue Multiple

Ainos, Inc. generates revenue through the sale of rapid tests and AI gadgets for respiratory biomarker analysis. The EV/Sales market multiple reflects the business valuation trend, with the metric currently fixed at 33138.46. Ainos, Inc. mitigates risks through software licensing and expansion in the US. Meanwhile, production automation and data analysis algorithms minimize the need for a large workforce.
AIMD (Ainos, Inc.): analytical breakdowns and indicator data

This indicator determines the market value of the business, accounting for net debt relative to the volume of generated sales, to identify whether the asset is fundamentally overvalued or undervalued. An analysis of enterprise value via EV/Sales allows for a comparison of Ainos, Inc. (AIMD) total capital with the effectiveness of its strategy to implement portable diagnostic systems and remote health monitoring devices in the home sector.